AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 19, 2024
(Peter Dazeley/The Image Bank/Getty Images) Our body’s circadian clock affects everything from sleepiness to metabolism – and it might also influence how effective certain cancer treatments are, according to recent research.
Pharmaceutical Technology
JUNE 19, 2024
IBI-343 is under clinical development by Innovent Biologics and currently in Phase I for Solid Tumor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 19, 2024
The Directorate General of Foreign Trade (DGFT), under the Union ministry of commerce & industry, has issued a directive addressing the issuance of Registration-Cum-Membership Certificate (RCMC) for medical devices.
Pharmaceutical Technology
JUNE 19, 2024
Polaroid Therapeutics’ CEO suggests that pharma should partner with medtech to prevent antibiotic resistance in wound management.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
JUNE 19, 2024
Congenital melanocytic naevus syndrome can cover up to 80% of the bodies of children
Pharmaceutical Technology
JUNE 19, 2024
Marea Therapeutics has launched with funding of $190m in a bid to develop cardiometabolic disease treatments.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JUNE 19, 2024
Unither Pharmaceuticals has announced a $106m investment to upgrade its Monroe County facility in New York, US.
pharmaphorum
JUNE 19, 2024
An AI-powered blood test that may be able to predict Parkinson’s years before symptoms develop could allow earlier treatment and guide trials of new treatments
Pharmaceutical Technology
JUNE 19, 2024
AbbVie has received FDA approval for SKYRIZI to treat adult patients with moderately to severely active ulcerative colitis.
pharmaphorum
JUNE 19, 2024
Discover the importance of data in the process of commercialising drugs for rare diseases and how it plays a critical role in advancing treatment options for patients. Learn more about orphan diseases and drug development.
Pharmaceutical Technology
JUNE 19, 2024
Ascidian has entered a research partnership and licensing agreement with Roche to develop RNA therapies for neurological diseases.
pharmaphorum
JUNE 19, 2024
Improving maternity care is crucial, and healthtech innovations can play a significant role in enhancing maternal health outcomes. Explore how technology can revolutionise maternal care.
BioSpace
JUNE 19, 2024
PTC Therapeutics said Thursday the FDA has lifted a partial clinical hold on its Huntington’s disease candidate PTC518 after displaying favorable clinical trends in a mid-stage study.
pharmaphorum
JUNE 19, 2024
Marea Therapeutics raises $190m for cardiometabolic pipeline, with Santa Ana Bio, Opthea, InduPro, Elion, and iOnctura also completing rounds
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
JUNE 19, 2024
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs.
pharmaphorum
JUNE 19, 2024
Novo Nordisk has been affected by a third fire in a month, the latest involving an office building near its Copenhagen headquarters.
XTalks
JUNE 19, 2024
The US Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), has allocated $31.4 million to enhance behavioral health services for racial and ethnic minorities. This significant investment aligns with the government’s commitment to addressing mental health and the overdose crisis.
pharmaphorum
JUNE 19, 2024
Sobi’s long-acting rVIII drug Altuvoct has been cleared for haemophilia A in the EU, with a label that spans all ages and any disease severity.
Pharmaceutical Commerce
JUNE 19, 2024
The latest news for pharma industry insiders.
pharmaphorum
JUNE 19, 2024
Watch the exclusive interview with Henar Hevia and Carolyn Sousa at ASCO 2024 as they discuss the latest advancements in cancer research and treatment. Get insights and updates in this informative video.
Pharmaceutical Technology
JUNE 19, 2024
TYRA-200 is under clinical development by Tyra Biosciences and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma).
BioSpace
JUNE 19, 2024
Vaxxinity published data from an early-stage clinical trial showing that its investigative immunotherapy, UB-312, could improve movement in Parkinson’s disease and protect against pathological alpha-synuclein.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
JUNE 19, 2024
Anti-RANKL Monoclonal Antibody is under clinical development by Jiangsu Pacific Meinuoke Bio-Pharmarceutical and currently in Phase I for Osteoporosis.
BioSpace
JUNE 19, 2024
Four executives with collective decades spent at BMS, Roche, Astellas, Eli Lilly and more gave their insights on navigating a biopharma career during a Monday DIA panel in San Diego.
Pharmaceutical Technology
JUNE 19, 2024
IMA-203CD8 is under clinical development by Immatics and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma).
BioSpace
JUNE 19, 2024
A new observational study from the University of Iowa points to the potential of alpha-blocker drugs, commonly used to treat enlarged prostates, as a preventive therapeutic option for dementia with Lewy bodies.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JUNE 19, 2024
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Open-Angle Glaucoma.
BioSpace
JUNE 19, 2024
Gilead Sciences reported zero cases of HIV infection occurred in the lenacapavir candidate group, compared to 16 cases in the Truvada arm and 39 incidents for those treated with Descovy, Gilead’s approved daily PrEP pills.
Pharmaceutical Technology
JUNE 19, 2024
ILution travoprost is under clinical development by Glaukos and currently in Phase II for Ocular Hypertension.
BioPharma Reporter
JUNE 19, 2024
Catching cancer early can save lives because it can be treated before it spreads in the body.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
242 
Let's personalize your content